Clinical trial Recruiting at 3 sites Interventional Ages 50 and up

Cognitive empathy training for dementia caregivers

Official title: Effect of Cognitive Empathy Training on Dementia Caregivers

Run by Emory University · NCT06650527 · Data updated 2026-11-12

This study tests whether teaching caregivers of people with dementia to better understand emotions can improve their mental health and reduce inflammation in their bodies.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment118 (estimated)
SponsorEmory University
Academic / other
Locations3 sites (Atlanta, Georgia and 2 other locations)
StatusRecruiting
StartedFebruary 13, 2025
Main results expectedNovember 1, 2028
Study endsNovember 1, 2028
Registry record updatedAugust 18, 2026
Trial IDNCT06650527 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are caregivers living with their care recipient who have a high burden of care as indicated by a Zarit Burden Scale score of 19 or higher.

Probably not a fit

Patients who may not benefit include those with significant psychiatric illnesses, neurological disorders, or contraindications for MRI.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the impact of cognitive empathy training on the mental health, inflammation, and immune function of caregivers for individuals living with dementia. The primary aim is to determine the effectiveness of this training in enhancing caregiver well-being and reducing inflammation. Additionally, the study will explore the psychological and neurobiological mechanisms that underlie these improvements. Caregivers will undergo pre and post-intervention assessments, including blood spot collection and MRI sessions, to evaluate changes resulting from the training.

Why it matters

Potential benefit: If successful, this training could significantly improve the mental health and immune function of caregivers, leading to better care for individuals with dementia.

How similar studies have gone: Previous interventions aimed at supporting caregivers have shown benefits, particularly in enhancing coping skills, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Caregivers must live with their care recipient
* Caregivers must have a Zarit Burden Scale score of 19 or higher
* Caregivers must have no plans to move their care recipient to an institutional setting within the next year
* Caregivers must be able to read and write English
* Care recipient not in hospice
* Access to a mobile phone that can take and email photographs

Exclusion Criteria:

* Subjects with a history of seizures or other neurological disorders, alcoholism, or any other substance abuse
* Subjects with a history of psychiatric illness (excluding depression and anxiety disorders) will also be excluded
* Subjects with a history of head trauma based on Survey
* Subjects with MRI contra-indications

Where it's running

  • Alter
    Atlanta, Georgia, United States
    Recruiting
  • Emory Integrated Memory Care
    Atlanta, Georgia, United States
    Recruiting
  • NIA Goizueta Alzheimer's Disease Research Center
    Atlanta, Georgia, United States
    Recruiting

Study contacts

  • Principal investigator: James Rilling, PhD — Emory College of Arts & Sciences
  • Study coordinator: James Rilling, PhD
  • Email: jrillin@emory.edu
  • Phone: 404-727-3062

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.